TrialInternational journal of hematology2015

Unfavorable outcome of chronic myelogenous leukemia in adolescent and young adults treated with tyrosine kinase inhibitors.

Masatoshi Sakurai et al.PubMed ↗Publisher ↗

No numbers read from the abstract.